Post-chemotherapy cognitive dysfunction in women with breast cancer

Gorica Vuksanović; Jelena Marić; Olivera Kalajdžić; Ivana Zečević; Sandra Matovic; Siniša Ristić

doi:10.5937/BII2201095V

Reviews

Post-chemotherapy cognitive dysfunction in women with breast cancer

Authors

- Gorica Vuksanović
- University of East Sarajevo,Faculty of Medicine, Foca, The Republic of Srpska, Bosnia and Herzegovina,Bosnia and Herzegovina
- Jelena Marić
- University of East Sarajevo,Faculty of Medicine, Foca, The Republic of Srpska, Bosnia and Herzegovina,Bosnia and Herzegovina
- Olivera Kalajdžić
- University of East Sarajevo,Faculty of Medicine, Foca, The Republic of Srpska, Bosnia and Herzegovina,Bosnia and Herzegovina
- Ivana Zečević
- University of East Sarajevo,Faculty of Medicine, Foca, The Republic of Srpska, Bosnia and Herzegovina,Bosnia and Herzegovina
- Sandra Matovic
- University of East Sarajevo,Faculty of Medicine, Foca, The Republic of Srpska, Bosnia and Herzegovina,Bosnia and Herzegovina
- Siniša Ristić
- University of East Sarajevo,Faculty of Medicine, Foca, The Republic of Srpska, Bosnia and Herzegovina,Bosnia and Herzegovina

Abstract

Cancer-related cognitive dysfunction is an important clinical prob em that can interfere with the daily functioning, work productivi ty, childcare, and other responsibilities of women with a history of breast cancer. Risks of cancer-related cognitive impairment include cancer and cancer treatment, as well as patient-related vulnerabil ities. There is no established standard of neuroprotective care or treatment for breast cancer-related cognitive impairment.

Keywords: cancer-related cognitive impairment, breast cancer, women

How to Cite: Vuksanović, G. , Marić, J. , Kalajdžić, O. , Zečević, I. , Matovic, S. & Ristić, S. (2022) “Post-chemotherapy cognitive dysfunction in women with breast cancer”, Biomedicinska istraživanja. 13(1). doi: https://doi.org/10.5937/BII2201095V